Liquidia Technologies Stock Price - LQDA

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 4.07 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Liquidia Technologies Inc LQDA NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.04 -0.97% 4.07 4.16 4.051 4.16 4.11 17:59:51
Bid Price Ask Price Spread Spread % News
3.36 5.11 1.75 34.25% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
194 7,918 $ 4.09 $ 32,374 33,443 3.25 - 27.44
Last Trade Time Type Quantity Stock Price Currency
16:00:02 11 $ 4.07 USD

Liquidia Technologies Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 75.93M 18.66M $ -53.14M -1.70 4.80 18.32M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 6.00 1.80%

more financials information »

Liquidia Technologies News

Loading Messages....

Latest LQDA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LQDA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.154.374.0254.2027,228-0.08-1.93%
1 Month3.804.373.363.7042,2810.277.11%
3 Months4.205.313.363.9939,141-0.13-3.1%
6 Months9.549.623.255.5355,240-5.47-57.34%
1 Year24.3627.443.259.5869,426-20.29-83.29%
3 Years12.4538.463.2512.3272,167-8.38-67.31%
5 Years12.4538.463.2512.3272,167-8.38-67.31%

Liquidia Technologies Description

Liquidia Technologies Inc is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain.

Your Recent History
Liquidia T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.